Diffuse Correlation Spectroscopy for Noninvasive Monitoring of Peripheral Perfusion During Cardiogenic Shock and
Hiroki Matsushita1, Kenta Oba1, Koki Kurono2
1Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center Research Institute, Suita, Japan.
Shock (Augusta, Ga.)
|March 26, 2026
Summary
Diffuse correlation spectroscopy (DCS) effectively monitored microvascular blood flow in cardiogenic shock (CS) patients on venoarterial extracorporeal membrane oxygenation (VA-ECMO). DCS identified persistent microcirculatory impairment, aiding therapy optimization.
Area of Science:
- Cardiovascular Research
- Biomedical Engineering
- Critical Care Medicine
Background:
- Persistent microcirculatory impairment in cardiogenic shock (CS) despite improved macrocirculation predicts poor outcomes.
- Conventional methods for assessing microcirculation are limited, particularly during venoarterial extracorporeal membrane oxygenation (VA-ECMO).
- Diffuse correlation spectroscopy (DCS) offers a novel, noninvasive approach for continuous microvascular blood flow monitoring.
Purpose of the Study:
- To evaluate the utility of DCS in monitoring microcirculation during CS under VA-ECMO support.
- To assess DCS's ability to detect changes in microvascular blood flow in response to hemodynamic interventions.
Main Methods:
- CS was induced in beagle dogs via coronary ligation and ventricular fibrillation.
- VA-ECMO was initiated, followed by controlled reductions in VA-ECMO flow and administration of vasoconstrictors.
- Continuous measurements included mean arterial pressure (MAP), cardiac output (CO), and DCS-derived blood flow index (BFI), alongside other microcirculatory parameters.
Main Results:
- CS induction led to significant drops in MAP, CO, and microcirculatory indices, with DCS detecting peripheral flow loss.
- VA-ECMO restored MAP and oxygen saturation, with gradual recovery of DCS-BFI and skin blood flow (SBF).
- Reduced VA-ECMO flow and vasopressor administration improved MAP but did not restore DCS-BFI, indicating persistent microcirculatory dysfunction.
Conclusions:
- DCS reliably tracked microvascular alterations in CS patients supported by VA-ECMO, irrespective of flow pulsatility.
- DCS shows promise for early detection of microcirculatory dysfunction in CS.
- This technique may aid in optimizing therapeutic strategies for CS patients on VA-ECMO.


